CD8A and acute myeloid leukemia: In AML patients who responded to chemotherapy, CD8+ T cells have regained a functional phenotype (expression of ICOS, CD28, downregulation of apoptotic and inhibitory transcripts), as revealed by transcriptomic analysis [213].